USD 0.01
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2024 | -0.00 USD | 60.0% |
2023 | -0.00 USD | 16.67% |
2022 | -0.00 USD | -700.0% |
2021 | 0.00 USD | 0.0% |
2020 | - USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q3 | - USD | 0.0% |
2024 Q4 | -0.00 USD | 0.0% |
2024 Q2 | - USD | 0.0% |
2024 Q1 | - USD | 100.0% |
2024 FY | - USD | 60.0% |
2023 Q2 | - USD | 100.0% |
2023 FY | - USD | 16.67% |
2023 Q4 | -0.00 USD | 0.0% |
2023 Q3 | -0.00 USD | 0.0% |
2023 Q1 | -0.00 USD | -50.0% |
2022 FY | - USD | -700.0% |
2022 Q1 | -0.00 USD | 0.0% |
2022 Q3 | - USD | 100.0% |
2022 Q2 | -0.00 USD | 0.0% |
2022 Q4 | -0.00 USD | 0.0% |
2021 Q2 | -0.00 USD | 99.65% |
2021 FY | - USD | 0.0% |
2021 Q4 | - USD | -100.0% |
2021 Q3 | 0.22 USD | 73433.33% |
2021 Q1 | -0.09 USD | 0.0% |
2020 FY | - USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
China Medicine Corporation | 0.11 USD | 100.182% |
Exlites Holdings International, Inc. | -0.00 USD | 90.476% |
Itonis, Inc. | - USD | Infinity% |
One Step Vending Corp. | -0.00 USD | -100.0% |
MediPal Holdings Corporation | 1.29 USD | 100.016% |
PD-Rx Pharmaceuticals, Inc. | -0.06 USD | 99.667% |
Pharmagen, Inc. | -0.02 USD | 98.81% |
Suzuken Co., Ltd. | 2.36 USD | 100.008% |